Amoxicillin-Clavulanate 600mg/5mL Oral Suspension from Japan
Combination powder for oral suspension with amoxicillin and clavulanic acid (beta-lactamase inhibitor) for resistant infections like sinusitis. Still classified in HTS 3004.10.50.55 as primarily penicillin-based for oral suspension in therapeutic doses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Declare clavulanate content accurately; ensure dual-API stability testing
• Pitfall: confusing with plain amoxicillin headings